Bio-Reference Labs, Buying GeneDx, Will Consider Entering PGx Space | GenomeWeb
NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today said that it will consider expanding into pharmacogenomics testing now that it will acquire specialty testing shop GeneDx.
 
Entering the molecular diagnostics market, including the drug-monitoring space, is one option that is “on the table,” Amar Kamath, marketing director for Bio-Reference’s molecular business, told GenomeWeb News today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.